Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Public ClinicalTrials.gov record NCT02261883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Intravenous Remodulin (Treprostinil) as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn: A Randomized, Placebo-Controlled, Safety and Efficacy Study
Study identification
- NCT ID
- NCT02261883
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- United Therapeutics
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Interventions
- IV Remodulin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Hour to 14 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 28, 2015
- Primary completion
- Sep 26, 2022
- Completion
- May 16, 2023
- Last update posted
- Mar 4, 2024
2015 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 13
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| Stanford Children's Hospital | Palo Alto | California | 94304 | — |
| All Children's Hospital | St. Petersburg | Florida | 33701 | — |
| Ann and Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Johns Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| University of Mississippi Medical Center - Baston Children's Hospital | Jackson | Mississippi | 39216 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| Columbia University Medical Center | New York | New York | 10032-3784 | — |
| Nationwide Childrens Hospital | Columbus | Ohio | 43205 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| University of Virginia Health Systems (UVA) | Charlottesville | Virginia | 22908 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
| Children's Hospital of Wisconsin | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02261883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2024 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02261883 live on ClinicalTrials.gov.